Some time has been lost dealing with this procedural matter, but now Ms. Stunteback’s case can resume progressing toward substantive resolution in the state court.
Rockville Centre, NY (PRWEB) September 09, 2014
According to an opinion filed in Stunteback v. Janssen et al. (case no. 14-1097; United States District Court for the Eastern District of Pennsylvania), the case should not have been removed to federal court from state court by Defendant Janssen Ortho, LLC because not all of the defendants—which include three Janssen entities and four Bayer entities—were served with the original complaint filed with the Philadelphia Court of Common Pleas. As set out in Judge Joel Slomsky’s order, “Plaintiff [Virginia Stunteback] seeks damages for injuries allegedly caused by the prescription medication Xarelto, which is manufactured and distributed by Defendants.”
“Fortunately, Judge Slomsky saw through Janssen’s attempt to ‘manipulate the operation of the removal statute,’ as he put it in his opinion,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. “Some time has been lost dealing with this procedural matter, but now Ms. Stunteback’s case can resume progressing toward substantive resolution in the state court.”
In 2013, the U.S. FDA received several hundred adverse event reports submitted by individuals who claimed to have a serious adverse side effect while taking Xarelto (rivaroxaban).* Data show that the number of persons being prescribed these blood thinning drugs is estimated at about 4 million for the year.* Anticoagulants (or “blood thinners”) are considered high-risk prescription drugs because they reportedly can cause excessive internal bleeding and other injuries in some patients.
Anyone needing more information about the potential dangers of Xarelto should visit the firm’s Xarelto page at http://www.xareltolawsuit.us. Representatives of the firm are available to answer any questions, and there is a confidential, no-cost claim evaluation form that can be filled out in order to determine if one has grounds to file a Xarelto lawsuit.
ABOUT THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)
The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
100 Merrick Road Suite 226W
Rockville Centre, NY 11570
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com